Survey From Fox Chase and Other Institutions Finds Majority of Practitioners in Hereditary Gastroenterology Support Use of Genetic Testing to Determine Colorectal Cancer Risk, Treatment
PHILADELPHIA (October 30, 2023) — A majority of clinicians with expertise in hereditary gastroenterology support implementing genetic screening known as universal germline testing for the diagnosis of colorectal cancer, according to the results of a clinical practice survey conducted by Sanjeevani Arora, PhD, an Assistant Professor in the Cancer Prevention and Control Research Program at Fox Chase Cancer Center.